These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6547726)

  • 1. The determination of effective antiviral doses using a computer program for sigmoid dose-response curves.
    Taylor JL; O'Brien WJ; Goldman AI
    J Virol Methods; 1984 May; 8(3):225-32. PubMed ID: 6547726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The sensitivity of acyclovir-resistant mutants of herpes simplex virus to other antiviral drugs.
    Field H; McMillan A; Darby G
    J Infect Dis; 1981 Feb; 143(2):281-5. PubMed ID: 6260876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Novel 5,6-Dimethoxyindan-1-one Derivatives as Antiviral Agents.
    Patil SA; Patil V; Patil R; Beaman K; Patil SA
    Med Chem; 2017; 13(8):787-795. PubMed ID: 28359234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential sensitivity of herpes simplex virus types 1 and 2 to human interferon: antiviral effects of interferon plus 9-beta-D-arabinofuranosyladenine.
    Lerner AM; Bailey EJ
    J Infect Dis; 1976 Oct; 134(4):400-4. PubMed ID: 185303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New properties of trental as an inhibitor of viral activity with a wide range of activity].
    Amvros'eva TV; Votiakov VI; Andreeva OT; Vladyko GV; Nikolaeva SN; Orlova SV; Azarova IA; Zgirovskaia AA
    Vopr Virusol; 1993; 38(5):230-3. PubMed ID: 8284924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study on the apparent resistant strains of herpes simplex virus type 1 against 9-beta-D-arabinofuranosyladenine.
    Yoshida T; Suzutani T; Azuma M
    Tohoku J Exp Med; 1988 Nov; 156(3):279-90. PubMed ID: 2855280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A computer-assisted technique for analysis and comparison of dose-response curves.
    Cook DA; Bielkiewicz B
    J Pharmacol Methods; 1984 Apr; 11(2):77-89. PubMed ID: 6546959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antiviral activity of 9-beta-D-arabinofuranosyladenine is enhanced by the 2',3'-dideoxyriboside, the 2',3'-didehydro-2',3'-dideoxyriboside and the 3'-azido-2',3'-dideoxyriboside of 2,6-diaminopurine.
    Balzarini J; De Clercq E
    Biochem Biophys Res Commun; 1989 Feb; 159(1):61-7. PubMed ID: 2538128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral properties of 4-amino-(D3)-trishomocubanes.
    Oliver DW; Dekker TG; Snyckers FO
    Arzneimittelforschung; 1991 May; 41(5):549-52. PubMed ID: 1654909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative potencies of anti-herpes compounds.
    Collins P; Bauer DJ
    Ann N Y Acad Sci; 1977 Mar; 284():49-59. PubMed ID: 280147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The emergence of viruses resistant to antiviral agents: a new challenge].
    Boivin G
    Union Med Can; 1993; 122(1):31-6. PubMed ID: 8465473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy of herpetic keratitis induced by acyclovir-resistant strains of herpes simplex virus type 1.
    O'Brien WJ; Taylor JL
    Am J Med; 1982 Jul; 73(1A):294-9. PubMed ID: 6285720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploration of (hetero)aryl Derived Thienylchalcones for Antiviral and Anticancer Activities.
    Patil V; Patil SA; Patil R; Bugarin A; Beaman K; Patil SA
    Med Chem; 2019; 15(2):150-161. PubMed ID: 29792154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic antiviral activity of acyclovir and vidarabine against herpes simplex virus types 1 and 2 and varicella-zoster virus.
    Suzuki M; Okuda T; Shiraki K
    Antiviral Res; 2006 Nov; 72(2):157-61. PubMed ID: 16797734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of antiviral substances on herpes simplex virus type 1 in cell culture].
    Shishkov S; Pancheva S
    Acta Microbiol Bulg; 1989; 24():9-14. PubMed ID: 2560322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiplicity dependence and sensitivity of herpes simplex virus isolates to antiviral compounds.
    Harmenberg J; Wahren B; Sundqvist VA; Levén B
    J Antimicrob Chemother; 1985 May; 15(5):567-73. PubMed ID: 2989239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral activity of sandalwood oil against herpes simplex viruses-1 and -2.
    Benencia F; Courrèges MC
    Phytomedicine; 1999 May; 6(2):119-23. PubMed ID: 10374251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of penciclovir in antiviral assays against herpes simplex virus.
    Bacon TH; Howard BA; Spender LC; Boyd MR
    J Antimicrob Chemother; 1996 Feb; 37(2):303-13. PubMed ID: 8707740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sensitivities to other antiviral drugs and thymidine kinase activity of aciclovir-resistant herpes simplex virus type 1].
    Nitta K; Shiota H; Naito T; Mimura Y
    Nippon Ganka Gakkai Zasshi; 1994 Jun; 98(6):513-9. PubMed ID: 8030564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes simplex acyclovir-resistant mutant in experimental keratouveitis.
    Boisjoly HM; Park NH; Pavan-Langston D; De Clercq E
    Arch Ophthalmol; 1983 Nov; 101(11):1782-6. PubMed ID: 6314952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.